Cargando…

Prostate-specific Antigen Density as a Proxy for Predicting Prostate Cancer Severity: Is There Any Difference between Systematic and Targeted Biopsy?

BACKGROUND: Prostate cancer screening with prostate-specific antigen (PSA) can result in unnecessary biopsies and overdiagnosis. Alternately, PSA density (PSAD) calculation may help support biopsy decisions; however, evidence of its usefulness is not concrete. OBJECTIVE: To evaluate the predictive v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arafa, Mostafa A., Farhat, Karim Hamda, Rabah, Danny M., Khan, Farrukh K., Mokhtar, Alaa, Al-Taweel, Waleed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634460/ https://www.ncbi.nlm.nih.gov/pubmed/37970462 http://dx.doi.org/10.4103/sjmms.sjmms_49_23

Ejemplares similares

Transperineal versus transrectal multi-parametric magnetic resonance imaging fusion targeted prostate biopsy
por: Rabah, Danny, et al.
Publicado: (2021)

False-positive magnetic resonance imaging prostate cancer correlates and clinical implications
por: Arafa, Mostafa A., et al.
Publicado: (2023)

Effectiveness of magnetic resonance imaging–targeted biopsy for detection of prostate cancer in comparison with systematic biopsy in our countries with low prevalence of prostate cancer: our first experience after 3 years
por: Arafa, Mostafa A., et al.
Publicado: (2021)

Knowledge and attitude of the population toward cancer prostate Riyadh, Saudi Arabia
por: Arafa, Mostafa A., et al.
Publicado: (2015)

Does shared decision making increase prostate screening uptake in countries with a low prevalence of prostate cancer?
por: Amin, Hussein Saad, et al.
Publicado: (2020)

Prostate cancer screening in a low prevalence population: Is it worth it?
por: Arafa, Mostafa A., et al.
Publicado: (2017)

Assessment of lower urinary tract symptoms in Saudi men using the International Prostate Symptoms Score
por: Arafa, Mostafa A., et al.
Publicado: (2015)

Prospective randomized trial of 100u vs 200u botox in the treatment of idiopathic overactive bladder
por: AlTaweel, Waleed, et al.
Publicado: (2011)

With increasing trends of prostate cancer in the Saudi Arabia and Arab World: Should we start screening programs?
por: Arafa, Mostafa A, et al.
Publicado: (2017)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

Prostate cancer small non-coding RNA transcriptome in Arabs
por: Shan, Jingxuan, et al.
Publicado: (2017)

Are There Any Developments in the Attitudes and Practices of Oncologists Regarding Fertility Preservation in Saudi Arabia After 12 Years?
por: Arafa, Mostafa A, et al.
Publicado: (2023)

Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients
por: Ryoo, Hyunsoo, et al.
Publicado: (2020)

Vitamin D status and its correlates in Saudi male population
por: Farhat, Karim H., et al.
Publicado: (2019)

Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
por: Schoots, Ivo G., et al.
Publicado: (2020)

Prostate-specific Antigen Density Variation Rate as a Potential Guideline Parameter for Second Prostate Cancer Detection Biopsy
por: Xie, Gan-Sheng, et al.
Publicado: (2016)

Prostate biopsy for elevated prostate specific antigen (PSA) – Indian perspective
por: Ragavan, N.
Publicado: (2014)

The Prostate Cancer Detection Rate on the Second Prostate Biopsy according to Prostate-Specific Antigen Trend
por: Kim, Hyung-Sang, et al.
Publicado: (2012)

Predictive Value of Neutrophil to Lymphocyte Ratio in the Diagnosis of Significant Prostate Cancer at Initial Biopsy: A Comparison with Free Percent Prostate Specific Antigen, Prostate Specific Antigen Density and Primary Circulating Prostate Cells
por: Murray, Nigel P, et al.
Publicado: (2019)

An overview of serum prostatic surface antigen cut points for recommendation of prostatic biopsy
por: Patwardhan, Sujata K., et al.
Publicado: (2018)

Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer
por: Boo, Youngjun, et al.
Publicado: (2023)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

Is Prostate Biopsy Essential to Diagnose Prostate Cancer in the Older Patient with Extremely High Prostate-Specific Antigen?
por: Jang, Jee Young, et al.
Publicado: (2012)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
por: Park, Yong Hyun, et al.
Publicado: (2014)

Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?
por: Kim, Sang Jin, et al.
Publicado: (2015)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

The meaning of sampling density in multiple repeat prostate biopsies
por: Hrbáček, Jan, et al.
Publicado: (2016)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
por: Shahab, Ahmad Anies, et al.
Publicado: (2013)

Study of quality of life and its determinants in patients after urinary stone fragmentation
por: Arafa, Mostafa A, et al.
Publicado: (2010)

Is there any association between National Institute of Health category IV prostatitis and prostate-specific antigen levels in patients with low-risk localized prostate cancer?
por: Doluoglu, Omer Gokhan, et al.
Publicado: (2016)

The use of prostate specific antigen density to predict clinically significant prostate cancer
por: Yusim, Igor, et al.
Publicado: (2020)

Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer
por: Zou, Bing-Zi, et al.
Publicado: (2023)

A safe technique of finger-guided biopsy of the prostate
por: Darlington, C Danny
Publicado: (2019)

Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
por: Nath, Chandan Kumar, et al.
Publicado: (2020)

What should be done to minimize pain without any sexual function deterioration in transrectal prostate biopsy?
por: Sönmez, Mehmet Giray, et al.
Publicado: (2017)

Can Prostate-Specific Antigen Density Be an Index to Distinguish Patients Who Can Omit Repeat Prostate Biopsy in Patients with Negative Magnetic Resonance Imaging?
por: Yu, Jiwoong, et al.
Publicado: (2021)

New model of PIRADS and adjusted prostate-specific antigen density of peripheral zone improves the detection rate of initial prostate biopsy: a diagnostic study
por: Huang, Chen, et al.
Publicado: (2022)

Nonspecific Presentation of a Multiloculated Prostatic Abscess After Transurethral Prostatic Biopsy for Elevated Prostate-specific Antigen Level
por: Gandhi, Nilay M., et al.
Publicado: (2014)

High-density tissue microarrays from prostate needle biopsies
por: McCarthy, F, et al.
Publicado: (2010)

Role of Prostate-Specific Antigen Change Ratio at Initial Biopsy as a Novel Decision-Making Marker for Repeat Prostate Biopsy
por: Lee, Jung Gon, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mg6eaj1v2t3q0h4onluu0o5i86